Effect of an implantable cardioverter defibrillator with atrial detection and shock therapies on patient-perceived, health-related quality of life

American Heart Journal

Volumn 145, Issue 5, 2003, Pages 841-846

  Newman, David M ^a   Dorian, Paul ^a   Paquette, Miney ^a   Sulke, Neil ^b   Gold, Michael R ^c   Schwartzman, David S ^d   Schaaf, Katie ^e   Wood, Kathy ^e   Johnson, Linda ^e  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b Eastborne Hospital   (United Kingdom)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e MEDTRONIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CONVULSIVE THERAPY; DAILY LIFE ACTIVITY; DEFIBRILLATOR; DISEASE SEVERITY; FEMALE; FUNCTIONAL ASSESSMENT; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART PACING; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PATIENT ATTITUDE; PRIORITY JOURNAL; QUALITY OF LIFE; SELF REPORT; SOCIAL BEHAVIOR; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0037727953     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(02)94817-9     Document Type: Article

References (11)

1. Gold MR, Sulke N, Schwartzman DS, et al. Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias. J Cardiovasc Electrophysiol 2001;12:1247-53.
2. Dorian P, Jung W, Paquette M, et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol 2000;36:1303-9.
3. Ware JE Jr. SF-36 health survey: manual and interpretation guide. Boston: The Health Institute, New England Medical Center; 1993.
4. Maglio C, Sra J, Paquette M, et al. Measuring quality of life and symptom severity in patients with atrial fibrillation [abstract]. Pacing Clin Electrophysiol 1998;21:839.
5. Jung W, Herwig S, Camm J, et al. Impact of atrial fibrillation on quality of life: a prospective, multicenter study [abstract]. Pacing Clin Electrophysiol 1998;21:981.
6. McHorney CA, Ware JE Jr, Rogers W, et al. The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Med Care 1992;30:253-65.
7. Shipper HS, Clinch JJ, Olweny CLM. Quality of life studies: definitions and conceptual issues. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadephia: Lippincott-Raven Publishers; 1996. p. 11-23.
8. Lönnerholm S, Blomström P, Nilsson L, et al. Effects of the Maze operation on health-related quality of life in patients with atrial fibrillation. Circulation 2000;101:2607-11.
9. Dorian P, Paquette M, Newman D, et al. Quality of life improves following treatment in the Canadian Trial of Atrial Fibrillation. Am Heart J 2002;143:984-90.
10. Bubien RS, Knotts-Dolson SM, Plumb VJ, et al. Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. Circulation 1996;94:1585-91.
11. Irvine J, Dorian P, Baker B, et al. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J 2002;144:282-9.